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Dental implant-supported rehabilitations are safe and predictable therapies \[[@CR1]--[@CR5]\] whose rising demand varies according to the patient population ages \[[@CR6]\]. Clinicians are in continuous search for solutions to minimize biological and mechanical complications related to the implants over the time.

Patients' susceptibility to periodontitis, cigarettes smoke \[[@CR7]\], and the implant surface features \[[@CR8]\] seemed to be the parameters closely related to the early onset of peri-implant diseases after implant osseointegration. It was reported \[[@CR9]\] that a variable percentage, ranging from 8.6 to 14.4%, of restored implants are easily affected by peri-implantitis within 5 years after functional loading. A more recent literature review \[[@CR10]\] revealed an implant survival rate of 97.3% after 5 years or more of loading with less than 5% of the implants affected by peri-implantitis.

Achievement of implant stability and maintenance of stable crestal bone level are prerequisites for a successful long-term function of oral implants \[[@CR11]\]. In non-pathological conditions, after implant insertion and prosthetic loading, marginal bone loss appears more pronounced during the first year in function continuing slowly thereafter. It has been assumed that marginal bone resorption around implants represents a reaction to treatment and is not at all a disease process rather than an initial foreign body response to the implant \[[@CR12]\]. The amount of initial crestal remodeling has been observed to be related to host factors, implant design, surgical protocol, and restorative protocols \[[@CR13]\]. The prevalence and reasons for crestal bone loss during functional load are well documented \[[@CR14]\] in the literature, but it is still unclear, owing to the great number of factors. Implant geometry, surface features \[[@CR10]\], neck design \[[@CR15]\], or the micro-gap between fixture and abutment seemed to be all involved in peri-implant bone remodeling phenomena. A recent review demonstrated that crestal bone levels are better maintained in the short-medium term when internal fixture-abutment connections are adopted, and among them, conical connections seem to be more advantageous, showing lower peri-implant bone loss \[[@CR16]\].

The long-term implant success rate could also be influenced by other factors such as patient systemic disease \[[@CR17]\], tobacco smoke \[[@CR18]\], untreated periodontitis \[[@CR19]\], surgical technique \[[@CR20]\], host bone density \[[@CR21]\], fixture macro- and micro-geometry \[[@CR22]\], and implant surface \[[@CR23]--[@CR25]\].

It seems that surface topographies are a modifiable factor that influence physiologic and pathologic marginal bone loss, and different implant surfaces have been developed over the years in order to increase the speed of bone apposition during osseointegration phase and prevent bacterial adhesion \[[@CR26]\].

An innovative laser-modified implant surface seems to be able to promote titanium osteointegration and, at the same time, to inhibit biofilm formation compared to sandblast surface. The laser used to create this surface was pulsed by a diode-pumped solid state (DPSS) source laser, in a Q-Switch output rate. The DPSS Nd:Yag Q-sw laser is characterized by a very high speed and flexibility in this type of work. In fact, it is possible to carry out precise and repeatable micro-workmanship with micrometric tolerance, allowing the application of technology even in very inclined areas of the surface. With this technique, the material is removed from the surface as vapor and this "cold" ablation assures a "clean" finish without thermally altered areas, without the formation of cracks, and with good repeatability of the process \[[@CR27]\].

Many authors have previously investigated this innovative titanium surface treatment using in vitro and in vivo animal studies, but before the present paper, no study published human clinical outcomes.

An in vitro study \[[@CR28]\] evaluated and compared the amount of biofilm produced by *Staphylococcus aureus*, *Pseudomonas aeruginosa*, and *Porphyromonas gingivalis* on conventional sandblasted titanium and on laser-treated surface. Results showed a lower biofilm production on laser-modified surface compared to the sandblasted one. Other authors \[[@CR29]\] demonstrated a higher albumin and fibronectin adsorption compared to sandblast or machined surfaces, and it is reported to have an average bone loss of 0.73--0.84 mm the first year in function.

Despite the promising properties, little evidence is available on longer-term function of this type of implants.

The aim of the study was to evaluate the marginal bone level, implant survival rate, and peri-implant prevalence of this particularly laser-modified implant surface.

Materials and methods {#Sec2}
=====================

This retrospective study was conducted by analyzing X-rays from patients treated with at least one way Milano implants with Synthegra® laser-treated surface (Geass srl, Pozzuolo Del Friuli, Udine, Italy) from four private practices in Italy (Udine, Arezzo, Frascati, Roma) between 2008 and 2013. The protocol followed the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Sapienza University (Rome, Italy) (ref. 3339/27.11.2014). All patients signed the informed consent on the use of personal information related to the aim of the study.

No restriction on systemic or local characteristics was applied other than those necessary for undergoing an oral surgery procedure of dental implant insertion by an expert in implantology. The only inclusion criteria were at least one Synthegra® dental implant and clear peri-apical X-rays of implant insertion (T0), time of loading (T1), and last recall (T2). The time of loading (T1) coincided with the final restoration delivery. Some exemplificative cases are shown in Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, and [3](#Fig3){ref-type="fig"}. The last recall was restricted to a minimum of 1 year after restoration delivery. Implants with incomplete radiological documentation were excluded from the study. Fig. 1Illustrative case of radiological follow-up period in the mandible. T0 in the left image, T1 in the central, and T2 in the rightFig. 2Illustrative case of radiological follow-up period in the upper jaw. T0 in the left image, T1 in the central, and T2 in the rightFig. 3Illustrative case of radiological follow-up period of two adjacent implants in the maxilla. T0 in the left image, T1 in the central, and T2 in the right

All patients were treated with the same dental implant type following the manufacturer's drill sequence for the osteotomies using sharp instruments; drill speed was between 700 and 1000 rpm under abundant sterile saline irrigation to minimize bone trauma.

The implant diameters used, compared to the total, were 2.14% for 3.4 mm, 38.33% for 3.8 mm, 53.57% for 4.5 mm, and 5.95% for 5.5 mm. The most used fixture length was the 12 mm (23.10% of cases) followed by the 11 mm (19.29% of cases), 13 mm (18.33% of cases), 15 mm (15.71% of cases), 10 mm (13.33% of cases), 9 mm (8.33% of cases), and 8 mm (1.90% of cases).

The following parameters were monitored during the follow-up period and utilized to establish the peri-implantitis diagnosis: bleeding on probing presence, suppuration presence, probing pocket depth beyond the fixture-abutment connection level, and crestal bone loss more than 2 mm in respect to the bone level at baseline (final restoration deliver).

The maintenance implant protocol included recall visit every 6 months with professional oral hygiene and measurement of clinical parameters such as plaque index (PI), full-mouth plaque score (FMPS), and full-mouth bleeding score (FMBS).

The health scale specific for endosteal implants, according to the ICOI Pisa Consensus Conference \[[@CR30]\], was used in the present study in order to classify implant into categories of success, survival, or failure. The implant success has been associated to pain absence, 0 mobility, \< 2 mm radiographic bone loss from initial surgery, and no exudates history. Implant satisfactory survival has been associated to pain absence, 2 to 4 mm of radiographic bone loss, and no exudates history.

The method used for bone measurements was described in detail in Zeza et al. \[[@CR31]\]. Briefly, mesial and distal marginal bone level was recorded for each implant. Conventional periapical radiographs were obtained using the long-cone paralleling technique when the implant was put in function and on the most recent visit. Acceptable radiographs (visible full length of the implant and clearly distinguishable implant threads) were imported to the software used for bone-level measurements (CSN Image Database®, Version 3.14, ArchiMed, Turin, Italy). Following image and measurement calibration, based on actual implant length as recorded in the chart, the original image size was enlarged × 1.5 and the implant platform shoulder was used as reference point for bone level measurements. Mesial and distal bone level measurements, performed by a trained and calibrated examiner (BZ), were recorded and analyzed separately. Examiner reliability was assessed by performing duplicate measurements, 1 week apart, on 40 randomly chosen distinct radiographs; difference between duplicate measurements was \< 0.5 mm. Radiographic distance between bone crest and implant platform more than 2 mm were identified as peri-implantitis bone loss.

Bone level measurements were organized in Excel and transferred to Stata13.1 (StataCorp LP; College Station, TX, USA). Descriptive analysis was performed to summarize the general information on patient level and determine the bone level around implants at the two different time periods.

Results {#Sec3}
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All implants had a small thread design, with smooth neck of 0.25 mm in the most coronal area and a micro-thread collar of 3.25 mm in length. The thread angle was 60°, and the screw pitch was 0.6 mm. The fixtures showed a 22° conical internal hexed prosthetic connection with platform switching. The conical portion height was 1.5 mm for 3.4/3.8 implant diameters and 2.2 mm for 4.5/5.5 implant diameters while the hexagon height was 1.4 mm for all implants.

All implants showed a laser-treated surface characterized by a series of 20-μm-diameter holes (7--10 μm deep) every 10 μm. The *R*~a~ value was 0.37 μm (value obtained considering the holes not as part of the roughness but as part of the primary profile. *R*~a~ inside the holes is 0.1 μm while outside the holes is 0.4 μm). Implants had internal hexagon associated to a conical connection.

A total of 502 implants, inserted in 263 patients, were monitored with a maximum follow-up period of 6 years (Table [1](#Tab1){ref-type="table"}). Patients' mean age was 60 ± 12 years. The distribution of implant sites is summarized in Table [2](#Tab2){ref-type="table"}. Table 1Number of patients treated and implants inserted in each center of the present retrospective multi-centric analysisCenter 1Center 2Center 3Center 4TotalPatients no.75657944263Implants no.17310114682502Table 2Distribution of implant sitesImplant sitesCenter 1Center 2Center 3Center 4Total%**Upper molars**191321237615.20**Upper premolars**5041492816833.60**Upper canines**1891193.80**Upper incisives**1513145479.40**Lower molars**531726810420.80**Lower premolars**3091796513.00**Lower canines**105281.60**Lower incisives**5053132.60500100.00

Nine implants failed the osseointegration after 3 months, and the mean implant survival rate was about 98.1% while the mean implant success rate was 91.5%. Among failed implants, seven implants were inserted in the upper molar region.

After being in function for 1 to 6 years, implants reported varying behavior. While 8.8% of sites did not show any radiographic changes, 38.5% of sites showed bone resorption. The bone appeared to have been growing coronally in 50.7% of the sites measured. In center 4, greater bone loss than other centers was detected; this is probably caused by dependent operator variables.

Overall, only 8% of mesial sites and 10% of distal sites showed a bone resorption more than 2 mm. The prevalence of peri-implantitis was 5.8% at site level and 6.5% on implant level because only some sites with bone loss \> 2 mm showed also bleeding on probing and suppuration.

The mean differential of marginal bone loss between T0 (implant insertion) and T2 (last recall visit) was 0.05 ± 1.08 mm at the mesial aspect and 0.08 ± 1.11 mm at the distal with a mean follow-up period of 35.76 ± 18.05 months (Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}). The data distribution of each center is illustrated in Fig. [4](#Fig4){ref-type="fig"}. Table 3Mean differential of peri-implant bone loss/gain (mesial and distal) between T0 (implant placement) and T2 (last recall). The minimum follow-up period was set at 1 year post-functional load∆Mesial mmDev st∆Distal mmStan devMean loading time (months)Stan devCenter 1− 0.050.96− 0.060.8734.2514.97Center 20.180.910.151.1233.0319.31Center 3− 0.060.800.080.8143.2818.94Center 40.321.610.491.8035.9719.84**Total0.051.080.081.1135.7618.05**Table 4Mean peri-implant bone loss/gain between T1 (time of loading) and T2 (last recall) in each year post-functional loadLoading Time∆Mesial mmStan dev∆Distal mmStan devMean loading time (months)Stan dev**\> 2 years**0.051.110.131.1844.3114.44**\> 3 years**0.081.200.141.2751,2311.41**\> 4 years**0.131.160.231.2758.188.45**\> 5 years**0.241.230.391.3464.926.13**\> 6 years**0.160.690.110.5874.252.43Fig. 4Data distribution of marginal bone loss/gain between T0 (implant insertion) and T2 (last recall) of each center
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It was well documented \[[@CR32], [@CR33]\] that titanium surface composition, hydrophilicity, and roughness are parameters which may play a key role in implant--tissue interaction and osseous integration.

Data from the present investigation demonstrated that bone level around laser-modified implants in function for 36 ± 18 months showed a mean change of 0.05 ± 1.8 mm for mesial sites and − 0.08 ± 1.11 mm for distal sites. Despite the mean values giving the impression of an overall tendency of a growth of bone around this type of implant surface, only 50.7% of sites behaved that way.

However, the maintenance of marginal bone levels in time was similar and in some cases even better than the values reported in the literature for the most commonly known implants \[[@CR34], [@CR35]\]. The values of bone change during the selected period of time showed different tendency and were considerably lower than previously reported studies on the same implant surface. A bone loss of 0.73 mm the first year in function was reported by Felice et al. \[[@CR36]\]. A recent retrospective study on 174 patients \[[@CR37]\] that evaluated the marginal bone loss around implants with laser micro-grooved collar found mean peri-implant bone resorption of 0.18 ± 0.7 mm at the mesial aspect and 0.19 ± 0.6 mm at the distal aspect. Similar results were also reported from the study of Acharya et al. \[[@CR38]\], in which the authors performed an exploratory analysis of annual rates of peri-implant marginal bone loss using the same three radiographical intervals used by the present retrospective study (immediately post-implant placement, time of loading, at least 1 year post-loading), and they found an overall peri-implant marginal bone loss of 0.21 mm/year. Regarding other implant surfaces and systems, the pooled mean marginal bone level change amounted to − 0.24 mm (95% CI − 0.345, − 0.135) for the Astra Tech Dental Implant System, 0.75 mm (95% CI − 0.802, − 0.693) for the Brånemark System, and 0.48 mm (95% CI − 0.598, − 0.360) for the Straumann Dental Implant System over 5 years \[[@CR39]\]. Another study evaluating peri-implant bone level changes around surface-modified implants reported a mean bone loss of 0.36 mm from the time of implant placement for implants in function for a mean 32 months \[[@CR40]\].

A literature review study, on peri-implant bone loss over the time \[[@CR41]\], that examined 758 international studies found an implant survival rate after 12 months of healing of 97.4% for the maxilla and 99.6% in the mandible. The authors reported that the peri-implant crestal bone loss, after 1 year of functional prosthetic load, ranged from 0.43 to 1.13 mm.

The laser technique used allowed to create a pure titanium surface without any contamination (no contact between titanium and the machinery during the production), inorganic residuals from blasting procedure, or residual acid that could pollute the titanium surface purity. The laser surface used is characterized by a series of 20-μm-diameter holes (7--10 μm deep) every 10 μm (Fig. [5](#Fig5){ref-type="fig"}). Fig. 5Scanning electron microscopy (SEM) picture of Synthegra® surface. The laser surface is characterized by a series of 20-μm-diameter holes (7--10 μm deep) every 10 μm

Sinjari et al. \[[@CR42]\] evaluated the effects of different titanium surface treatments on blood clot formation, and they demonstrated in vitro that the laser-conditioned surface, although it has a low roughness value (*R*~a~ of 0.25  ±  0.02 μm) compared to a standard grit-blasted surface (*R*~a~ of 1.30  ± 0.03 μm), had higher wettability and blood clot extension in respect to machined and rough surfaces.

It has been speculated that the initial peri-implant bone reaction could be rather a response to a foreign body by Albretksson et al. This assumption has the support of in vitro results of Quabius et al. \[[@CR43]\], observing an enhanced expression of IL-8 when the human blood is in contact with dental implants. Similarly, but in vivo results, Salvi et al. \[[@CR44]\] report levels of MMP-8 activity at the implant level higher at all the time points, even in healthy conditions, compared to the tooth level during the development of 21 days experimental mucositis and gingivitis. Both biomarkers are involved in periodontal tissue destruction during inflammation. In addition, the same authors concluded that the peri-implant tissue response is stronger to plaque accumulation than periodontal tissues. Bone loss at the first year in function was reported to be 0.02 mm \[[@CR45]\] compared to previously accepted physiological bone loss of 1.5 mm \[[@CR46]\]. Cases of regrowth of bone around dental implants following the first year in function, as in the present study, contradict all this theory and indicate the need for further examination and epidemiological evaluation of similar patients.

Trisi et al. \[[@CR47]\] demonstrated, in an in vivo animal study, that laser-treated implants had significant higher bone to implant contact percentages (%BIC) and reverse torque values in respect to machined implants. Other authors \[[@CR48]\] found no significant differences in %BIC values comparing laser-treated and sandblasted/acid-etched implants in sheep.

High implant success rate from the present study seemed to confirm the results showed by these cited studies.

Peri-implant diseases are infective complications of surrounding dental implant tissues that often occurs some years after the final prosthetic restoration placement. They represent a high risk of implant failure. A recent study, with a long follow-up \[[@CR49]\], demonstrated a peri-implantitis incidence of 7.9% on implant level.

Pjetursson et al. \[[@CR50]\] studied the 5- and 10-year survival of implant-supported fixed dental prostheses (FDPs) analyzing 32 studies that matched the criteria for the systematic review. They found a survival rate of implants supporting FDPs of 95.6% after 5 years and 93.1% after 10 years, but they observed that, when machined surface implant data were excluded from the analysis, the survival rate increased to 97.2% after 5 years.

The low incidence of peri-implantitis (less than 7%) observed in the present retrospective study could be attributed to the titanium surface features that seem to prevent bacterial colonization. This datum is similar to those reported by Pandolfi et al. \[[@CR51]\] that estimated a prevalence of peri-implantitis from 3.2 to 9.7%.

Laser treatment was analyzed by Di Giulio et al. \[[@CR52]\] by testing the biofilm formation of *Porphyromonas gingivalis* (in vitro) on disks made of titanium grade 4 and grade 5 with different surface topographies, and their results showed that titanium grade 4 with this laser treatment appears to be significantly less attractant for the *P. gingivalis* biofilm formation. These results were confirmed by another recent in vitro evaluation \[[@CR53]\] comparing in vitro and in situ biofilm formation on a laser-treated titanium surface, machined, and grit-blasted. Both in vitro and in situ results demonstrated the lowest biofilm formation on laser-modified surface characterized by a few dead microbial cells.

Moreover, there is evidence that an internal conical implant-abutment connection with platform switching is an efficient factor in maintaining stable bone levels around implants in function \[[@CR16]\]. Also, Gracis et al. \[[@CR54]\] demonstrated that short-term results of this connection are favorable while long follow-up study are needed to evaluate long-term outcomes. The platform-switching concept proposed by Lazzara et al. \[[@CR55]\] has been validated to reduce the peri-implant bone loss related to the microgap.

Conclusion {#Sec5}
==========

Laser-treated implants with 22° conical internal hexed connection showed a maintenance of marginal bone levels over time similar (better in many cases) of what is usually reported in the literature for most commonly known implants. The low peri-implant disease incidence recorded could be attributed to the laser titanium surface features (low roughness) that seems to prevent bacterial colonization, according to several studies. The laser technique to treat dental implant allowed to create a clean and repeatable titanium surface avoiding any contamination deriving from blasting or acid procedures. According to the authors, laser-modified implants can be used successfully for various prosthetic indications. Future randomized and controlled studies are needed to confirm the results of the present multi-centrical retrospective analysis.
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